Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease

Aimmune Therapeutics Discusses AR101's Cost-Effectiveness and Demonstrated Clinical Benefits at ICER Meeting

Viralym-M Granted Regenerative Medicine Advanced Therapy Designation for the Treatment of Hemorrhagic Cystitis Caused by BK Virus in Adults and Children Following Allogeneic HSCT

Bolder BioTechnology wins FDA's ODD for BBT-059 for treating ARS

eMurmur passes CE mark certification for its heart murmur detection eMurmur ID solution

FDA Grants Genentech's Polivy Accelerated Approval for People with Previously Treated Aggressive Lymphoma

BioCelerate Establishes Working Group with the FDA on Nonclinical Initiatives

Sesen Bio Reports Successful Pre-BLA Meeting with FDA for Vicinium

MetVital awarded US FDA clearance of IND Application for AEO for Phase 2 testing of brain cancer Glioblastoma Multiforme

Boston Scientific acquires Vertiflex Inc for USD465m

Genentech receives USFDA approval for Polivy combination

Aidoc wins US FDA clearance for world's first AI solution for C-spine fractures

CorMatrix Cardiovascular Inc passes US FDA 510(k) clearance for Cor PATCH epicardial patch for tissue support and repair in adult patients

EmCyte awarded US FDA 510(k) clearance for PureBMC Supraphysiologic Concentrating System to improve quality of bone marrow cell concentrate

Aratana Therapeutics to unveil US FDA approved NOCITA in 10 ml Vial by autumn 2019